Theranano was founded to translate nanomedicines from the lab to the clinic.
Theranano LLC has a strong pipeline of technologies based on discoveries in nanomedicines and medical imaging made in Professor Srinivas Sridhar’s laboratory at Northeastern University. The InCeRT platform for sustained delivery of chemotherapeutics is currently being scaled up for GMP and an IND filing is underway. We anticipate clinical trials on prostate cancer in 2021 in collaboration with Dana Farber Cancer Institute. A quantitative MRI method called QUTE-CE MRI uses magnetic nanoparticles to obtain vascular images with unprecedented clarity and definition, and is currently being tested in clinical trials for human brain imaging at Massachusetts General Hospital with funding from NIH. Nanoformulations of PARP and other inhibitors for cancer therapy are currently being tested in pre-clinical studies.
Company Details
- Address
- Newton Center, Ma 02459, Us
- Industry
- Nanotechnology Research
- NAICS
-
Research and Development in Nanotechnology
- Website
- http://theranano.com
- HQ
- Newton Center, MA
Theranano Llc Questions
Theranano Llc's website is http://theranano.com
Theranano Llc's LinkedIn profile is https://www.linkedin.com/company/theranano-llc
Theranano Llc's industry is
Nanotechnology Research
Theranano Llc's top competitors are
Extend Biosciences, Inc.,
Immunofuse,
Akirabio,
Wellesley Pharmaceuticals Llc,
Totalclarity, Inc.,
Borealis Biotechnology, Llc,
Endotarget,
Twentyeight-Seven, Inc.,
Manat Bio, Inc.,
Gelmedix.
Theranano Llc's categories are Nanotechnology Research
